UBS Maintains Neutral on Adient, Lowers Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Colin Langan maintains a Neutral rating on Adient (NYSE:ADNT) and lowers the price target from $43 to $40.
October 10, 2023 | 2:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst Colin Langan maintains a Neutral rating on Adient and lowers the price target from $43 to $40.
The news directly pertains to Adient as UBS analyst Colin Langan maintains a Neutral rating on the company and lowers the price target. This could potentially impact investor sentiment and the stock's short-term performance. However, as the rating remains Neutral, the price direction is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100